Document Actions
Jun
Up one level- Drug shows promise against advanced form of lung cancer
- CHAPEL HILL -- Results of a multi-center clinical study of a drug currently approved for treatment of kidney cancer indicate that it may also be effective for people with recurrent and advanced lung cancer.
- Study finds racial differences in response to treatments for advanced colon cancer; genetic factors may play a role
- CHAPEL HILL -- In recent years, reports have emerged showing that Americans with colorectal cancer who are black have a lower rate of survival compared with other racial or ethnic groups.
- Multimodality therapies trump surgery alone for treatment of esophageal cancer
- CHAPEL HILL -- Results of a multi-center study comparing treatment modalities for esophageal cancer show an advantage to undergoing multimodality therapy as opposed to one type of treatment.
- Study: Breast cancer in younger black women is more likely to be an aggressive variety
- CHAPEL HILL -- For decades, researchers have tried to understand why breast cancer in younger black women is such a significant public health problem.
- Improving sleep behaviors reduces frequency and intensity of headaches, UNC study shows
- CHAPEL HILL -- Women who suffer from "transformed migraine" experienced a significant reduction in headache frequency and intensity after taking simple steps to improve their sleep behaviors, a University of North Carolina at Chapel Hill study has found.
- Community conversation on genetics research, testing set for Saturday (July 1) at Durham coffee shop
- CHAPEL HILL -- Members of the general public interested in knowing more about genetic research and testing are invited to a community conversation in Durham Saturday (July 1).